FPN’s second annual Neuropathy Advocacy Day We held our second annual Neuropathy Advocacy Day on March 11. It was an important day to speak up for the 30 million Americans living with peripheral neuropathy. Together, we asked Congress to support more research and better care for people affected by this condition. Learn more about […]
“Science is a team sport” – Kristy Townsend, PhD Dr. Townsend recently spoke on our webinar, Behind the lab coat: How medical research really works. Kristy Townsend, PhD is a researcher and Professor in the Department of Neurological Surgery at The Ohio State University’s College of Medicine. Research in the Townsend Lab for Neurobiology & Energy Balance focuses on neural […]
Nominations Open: PRMRP Consumer Reviewer (Due March 17) The Congressionally Directed Medical Research Programs (CDMRP) is looking for new consumer reviewers to join upcoming scientific review panels. If you are a PN patient and want to review research grants, this opportunity is for you! This year, $370 million has been approved for the program. Peripheral […]
Critical funding restored for medical research After a huge cut in 2025, research funding for the Department of Defense’s Peer Reviewed Medical Research Program is finally back to its earlier level: $370 million. This is great news for people living with peripheral neuropathy. Each year, we work hard to make sure PN is one of the topics that can receive this funding. The more […]
The Foundation for Peripheral Neuropathy (FPN) is excited to share that the Brigham and Women’s Hospital has joined the IMAGiNe Study as a new research site. With help from FPN, they will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare autoimmune form of PN. About the IMAGiNe Study The IMAGiNe Study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical Center in the Netherlands. The study is creating a […]
Read More… from FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study
As we start a new year, we are excited to look back at what the IMAGiNe study achieved in 2025. We are also looking ahead to our goals for 2026 and beyond. At the Foundation for Peripheral Neuropathy (FPN), we celebrate every milestone that helps move peripheral neuropathy research forward. About the IMAGiNe study The IMAGiNe study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical […]
Read More… from IMAGiNe study progress: 2025 highlights and what’s ahead
November was Diabetes Awareness Month Diabetes affects millions of people. It is a major cause of peripheral neuropathy. Last month, we shared information to help you understand how diabetes develops. We explained why it can damage nerves, and what you can do to stay healthy. Learning the signs early and managing blood sugar can lower […]
Research update with Dr. Michelassi Francesco Michelassi, MD, PhD, Physician and Lead Scientist at the University of Virginia Health and the 2024 Clinical Research Training Scholarship (CRTS) recipient, shares his work studying Chemotherapy-Induced Peripheral Neuropathy (CIPN). He explains how his research could help protect nerves and lead to new treatments. Learn how FPN helped Dr. […]
Celebrating Jack Miller, FPN’s founder on FPN Day Tomorrow, FPN celebrates its 18th anniversary. In honor of our founding, we are proud to celebrate Jack Miller, the man who founded the Foundation for Peripheral Neuropathy. In his previous patient story from 2011, Jack shared the complete history of why he started FPN and his own long journey with peripheral neuropathy. […]
The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]
Read More… from FPN welcomes The Ohio State University as a new site for the IMAGiNe Study